NM_000384.3:c.8462C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000384.3(APOB):​c.8462C>T​(p.Pro2821Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00389 in 1,613,940 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P2821P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 14 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

3
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:12

Conservation

PhyloP100: 1.79

Publications

21 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077530444).
BP6
Variant 2-21008406-G-A is Benign according to our data. Variant chr2-21008406-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218451.
BS2
High Homozygotes in GnomAdExome4 at 14 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.8462C>Tp.Pro2821Leu
missense
Exon 26 of 29NP_000375.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.8462C>Tp.Pro2821Leu
missense
Exon 26 of 29ENSP00000233242.1

Frequencies

GnomAD3 genomes
AF:
0.00298
AC:
453
AN:
152028
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00420
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.00114
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00385
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00406
AC:
1021
AN:
251208
AF XY:
0.00449
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00252
Gnomad ASJ exome
AF:
0.00983
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00226
Gnomad NFE exome
AF:
0.00424
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00399
AC:
5831
AN:
1461794
Hom.:
14
Cov.:
37
AF XY:
0.00414
AC XY:
3010
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33472
American (AMR)
AF:
0.00246
AC:
110
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00838
AC:
219
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00834
AC:
719
AN:
86254
European-Finnish (FIN)
AF:
0.00217
AC:
116
AN:
53412
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5766
European-Non Finnish (NFE)
AF:
0.00393
AC:
4367
AN:
1111948
Other (OTH)
AF:
0.00402
AC:
243
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
382
764
1146
1528
1910
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00298
AC:
454
AN:
152146
Hom.:
0
Cov.:
33
AF XY:
0.00278
AC XY:
207
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.000723
AC:
30
AN:
41514
American (AMR)
AF:
0.00419
AC:
64
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4818
European-Finnish (FIN)
AF:
0.00114
AC:
12
AN:
10572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00385
AC:
262
AN:
68010
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00377
Hom.:
3
Bravo
AF:
0.00280
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00437
AC:
531
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00600
EpiControl
AF:
0.00421

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
1
1
Hypercholesterolemia, familial, 1 (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypercholesterolemia (1)
-
1
-
Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
20
DANN
Uncertain
0.99
Eigen
Benign
-0.075
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.41
N
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-0.83
T
PhyloP100
1.8
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-4.0
D
REVEL
Benign
0.097
Sift
Benign
0.051
T
Sift4G
Uncertain
0.014
D
Vest4
0.27
MVP
0.67
MPC
0.28
ClinPred
0.019
T
GERP RS
3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.67
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72653095; hg19: chr2-21231278; COSMIC: COSV51941169; API